Transcriptomics Technologies Market Regional Analysis:
North American Market Insights
Transcriptomics technologies market in North America region is predicted to hold largest revenue share of about 33% during the forecast period. The growth of the market is due to the rise in technological advancements and the expansion of drug discovery practices within the healthcare industry. The market expansion in North America is propelled by the existence of prominent industry participants such as Agilent Technologies and Thermo Fisher Scientific. The market for transcriptomics is being driven in North America by the increasing number of people suffering from infectious diseases, chronic illnesses, and cancer, as well as the growing need for innovative therapeutic options in research, diagnostics, and synthetic biology. According to CDC estimates, six out of ten persons in the US presently suffer from a chronic illness like diabetes, heart disease, or cancer. Heart disease and cancer combined account for around 38% of all deaths in the United States, making chronic diseases one of the main causes of death.
APAC Market Market Insights
Transcriptomics technologies market in Asia Pacific region is projected to hold second largest revenue share of about 27% during the forecast period. Transcriptomics is a rapidly expanding market in the APAC due to the rising demand for RNA-based NGS. Moreover, because of the technical advancements in biotechnology and pharmaceuticals in emerging countries like China and India, the transcriptomics technologies market in the Asia Pacific region is anticipated to rise over the forecast period.
